Treatment of Hypophysitis in Central Diabetes Insipidus

Hypophysitis can disrupt posterior pituitary function, resulting in Central Diabetes Insipidus (Central DI). This specific comorbidity shapes how treatment is selected and monitored in affected patients.

Clinical scenario

This protocol addresses Hypophysitis in the setting of Central Diabetes Insipidus. Central DI can develop as a consequence of hypophyseal inflammation and requires dedicated management. In some patients with partial Central DI, symptoms may be mild enough that no immediate intervention is necessary; the clinical picture guides the decision.

Treatment approach (partial overview)

Management centres on a specific antidiuretic agent, with the approach tailored to the severity and subtype of Central DI present. Patients with a particular variant of adipsic diabetes insipidus require especially careful, individualised management. Full regimen, dosing guidance, and algorithm available in the complete protocol →

Instant Access to Structured Evidence-Based Regimens

References

Central DI can be treated with desmopressin, but in some instances, partial DI might not bother the patient much and no treatment may be necessary.

Caution must be implemented in treating patients with adipsic DI, with careful adjustments of fluid intake and desmopressin based on urine output.

DOI: 10.1016/j.beem.2019.101371

View source ↗